PeproTech Revenue and Competitors

PeproTech was established in 1988 by a group of scientists who decided to focus their efforts on the development and production of recombinant cytokines for life-science research. Today, PeproTech is a world leader in supplying high quality cytokine products including E.coli, insect, and mammalian cell-derived recombinant proteins, their monoclonal/polyclonal antibodies, ELISA Development Kits, Cell Culture Media/Supplements, and other cytokine-related reagents. These products are distributed worldwide through customer-service offices in the US, UK, France, Germany, Israel, Korea, China, Japan, Brazil, and Mexico. We plan to maintain the highly competitive price of our products and to expand their distribution to Australia, New Zealand, and other locations. To keep up with current research and growing demand we have expanded our production capabilities to include a 5000 sq. ft. animal-free manufacturing facility. A key component in keeping up with current scientific advancements has been our collaboration with researchers in both academia and industry who provide us with suggestions necessary to continuously expand our product pipeline. We encourage you to convey to us your particular research needs and promise to do our best to fulfill them.